Published on March 20, 2019
Multiple Sclerosis (MS) Among Canadians
11 Canadians are diagnosed with MS every day. This makes up to 4,015 Canadians every year. MS is an autoimmune disease that effects the central nervous system disabling neurological function of young adults. Symptom includes blurred or double vision, hearing impairment, facial’s pain, tremors, reduced sense of taste and smell, etc.
According to research conducted by University of British Columbia and Vancouver Coastal Health, people who receive a beta interferon medication for at least six months to treat MS tend to survive longer than patients who had not taken it before, which leads to a 32 percent lower mortality risk. This potentially could encourage patients with MS to adhere to the prescribed dosing schedule.
Published on March 14, 2019
Mushrooms Help to Reduce Cognitive Decline
Mushroom is one of the main sources of food in the world. It has a very rapid cycle of growth which can be mass produce at once. People tend not know what mushroom provides to our health, instead they eat for pleasure. As the field of research has been growing exponentially, a new study has found that mushroom helps individuals with cognitive impairment.
Researcher has shown that mushroom has the potential of reducing the risk on cognitive decline. A compound found in mushroom called ergothioneine (ET) is a source of antioxidant and anti-inflammatory in which humans are unable to synthesize on their owned. Researcher also found individuals who has MCI tend to have a lower level of plasma level of ET compared with healthy individuals. This could explain that deficiency in ET can lead to neurodegeneration.